NCT03785327

Brief Summary

This study compares the efficacy of two intervention strategies for improving social outcomes for autistic adolescents and young adults when interacting with unfamiliar non-autistic peers.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
25 days until next milestone

Study Start

First participant enrolled

January 18, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2021

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

December 23, 2022

Completed
Last Updated

December 23, 2022

Status Verified

December 1, 2022

Enrollment Period

2.5 years

First QC Date

October 29, 2018

Results QC Date

November 9, 2022

Last Update Submit

December 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subjective Social Interaction Quality

    Non-autistic participants social interest in autistic partners as measured by the First Impression Scale (Sasson et al., 2017). Four items, each scored on a Likert Scale from 1 to 4 in which higher values indicate greater social interest, are averaged to produce a social interest composite that serves as the primary outcome measure of the non-autistic participant's social interest in their autistic conversation partner.

    Interaction with unfamiliar partner occurs immediately following the autism training; self-report measure given immediately after the interaction, duration of completion averages around 2 minutes

Study Arms (4)

Active anodal tDCS

EXPERIMENTAL

Active anodal tDCS followed by behavioral testing Intervention: Device: active anodal tDCS

Device: tDCS

Sham tDCS

SHAM COMPARATOR

Sham tDCS followed by behavioral testing Intervention: Device: sham tDCS

Device: tDCS

Autism Training Program

EXPERIMENTAL

Training program designed to increase autism understanding followed by behavioral testing Intervention:Training program

Behavioral: Autism Training

Social interaction without intervention

NO INTERVENTION

Control condition: Behavioral testing without an intervention component

Interventions

tDCSDEVICE

Participants either complete active and sham tDCS sessions one week apart or an autism training program.

Active anodal tDCSSham tDCS
Autism TrainingBEHAVIORAL

Autism Information Presentation developed by Dr. Grace Iarocci's Autism \& Developmental Disorders Lab at Simon Fraser University

Autism Training Program

Eligibility Criteria

Age18 Years - 21 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18-21
  • DSM-IV-TR or DSM-5 diagnosis of an Autism Spectrum Disorder
  • IQ\>70

You may not qualify if:

  • Presence or history intellectual impairment (defined as IQ \<70)
  • Presence or history of medical, cardiac, or neurological disorders that may affect brain function (e.g., cardiac disease, endocrine disorders, renal disease, pulmonary disease, history of seizures or head trauma with unconsciousness for a period of 15 minutes or greater or CNS tumors)
  • Presence of sensory limitation including visual (e.g., blindness, glaucoma, vision uncorrectable to 20/40) or hearing (e.g. hearing loss) impairments that interfere with assessment
  • Not proficient in English
  • Presence of substance abuse in the past one month
  • Presence of substance dependence not in remission for the past six months
  • Contraindications for tDCS (e.g., pregnancy or implanted devices such as pace maker)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas at Dallas

Richardson, Texas, 75080-3021, United States

Location

MeSH Terms

Conditions

Autism Spectrum Disorder

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Results Point of Contact

Title
Dr. Noah Sasson
Organization
The University of Texas at Dallas

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Autistic participants were going to be recruited for an active or sham tDCS session. However, no participants were enrolled in these conditions due to COVID. TD participants were assigned to receive or not receive a training session.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 29, 2018

First Posted

December 24, 2018

Study Start

January 18, 2019

Primary Completion

July 31, 2021

Study Completion

September 22, 2021

Last Updated

December 23, 2022

Results First Posted

December 23, 2022

Record last verified: 2022-12

Locations